Eltrombopag combining rituximab ( DrugBank: Rituximab, Eltrombopag )

1 disease

ID	Disease name (Link within this page)	Number of trials
63	Idiopathic thrombocytopenic purpura	1

63. Idiopathic thrombocytopenic purpura

Clinical trials : 391 / Drugs : 235 - (DrugBank : 50) / Drug target genes : 49 - Drug target pathways : 139

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04518475 (ClinicalTrials.gov)	August 10, 2020	12/8/2020	Eltrombopag Combining RituximabVersus Eltrombopag in the Management of Primary Immune Thrombocytopen ...	A Multicenter, Randomized, Open-label Study To Compare The Efficacy And Safety Of Eltrombopag Combin ...	Primary Immune Thrombocytopenia (ITP)	Drug: eltrombopag combining rituximab;Drug: eltrombopag	Institute of Hematology & Blood Diseases Hospital	The Second Affiliated Hospital of Kunming Medical University;Henan Cancer Hospital;Tianjin Medical U ...	Recruiting	18 Years	60 Years	All	224	Phase 4	China

First Previous1Next Last